Small-molecule BH3 mimetic and pan-Bcl-2 inhibitor AT-101 enhances the antitumor efficacy of cisplatin through inhibition of APE1 repair and redox activity in non-small-cell lung cancer

Tao Ren,1–3,* Jinlu Shan,1,* Mengxia Li,1 Yi Qing,1 Chengyuan Qian,4 Guangjie Wang,5 Qing Li,1,3 Guoshou Lu,1 Chongyi Li,1 Yu Peng,1 Hao Luo,1 Shiheng Zhang,1 Yuxing Yang,1 Yi Cheng,1 Dong Wang,1 Shu-Feng Zhou31Cancer Center, Daping Hospital and Research Institute of Surgery, Third Militar...

Description complète

Enregistré dans:
Détails bibliographiques
Auteurs principaux: Ren T, Shan J, Li M, Qing Y, Qian C, Wang G, Li Q, Lu G, Li C, Peng Y, Luo H, Zhang S, Yang Y, Cheng Y, Wang D, Zhou SF
Format: Artigo
Langue:Inglês
Publié: Dove Medical Press 2015-06-01
Collection:Drug Design, Development and Therapy
Accès en ligne:http://www.dovepress.com/small-molecule-bh3-mimetic-and-pan-bcl-2-inhibitor-at-101-enhances-the-peer-reviewed-article-DDDT
Tags: Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!

Documents similaires